Development of Epstein-Barr virus vaccines
Author(s)
Bibliographic Information
Development of Epstein-Barr virus vaccines
（Medical intelligence unit）
Springer-Verlag , R. G. Landes, c1995
- :U.S. and Canada
- :International
Available at / 3 libraries
-
No Libraries matched.
- Remove all filters.
Note
PRIORITY 2
Description and Table of Contents
- Volume
-
:U.S. and Canada ISBN 9781570591129
Description
This reference reviews the development of Epstein-Barr virus vaccines that may ultimately eliminate or reduce the incidence of the cancers associated with this virus in humans. These include nasopharyngeal carcinoma, endemic Burkitts lymphoma and certain lymphomas that occur with a relatively high frequency in immunosuppressed patients and AIDS sufferers. Such vaccines may also be deployed in the prevention of infectious mononucleosis, a disease that, although rarely fatal, has significant social and economic impact on the young adult population in the Western world. Human trials of the vaccines developed to date have not been carried out but are planned for the near future. Several candidate vaccines based on recombinant viral envelope glycoproteins and a range of viral vectors are evaluated in a primate animal model of lymphoma induced by the virus.
- Volume
-
:International ISBN 9783540588863
Description
This text describes the development of the Epstein-Barr virus vaccine, which may ultimately eliminate or reduce the incidence of the cancers associated with this virus in humans. These include nasopharyngial carcinoma, endemic Burkitts lymphoma and certain lymphomas which occur with a relatively high frequency in immunosuppressed patients and AIDS sufferers. Such vaccines may also be deployed in the prevention of infectious mononucleosis. Several candidate vaccines based on recombinant viral envelope glycoproteins and a range of viral vectors are evaluated in a primate animal model of lymphoma induced by the virus.
by "Nielsen BookData"
